Drug Formulary Review articles from September 2007

Drug Formulary Review archives from September 2007

Stand and deliver: Vaccine standing orders program boosts immunizations.
September 1, 2007... Stand and deliver: Vaccine standing orders program boosts immunizations Collaboration, education keys to boosting low pneumococcal rates Determined to improve a dropping in-hospital vaccination rate for pneumococcal polysaccharide...

Unsafe drug orders slipping through in Pennsylvania.
September 1, 2007... Unsafe drug orders slipping through in Pennsylvania Pharmacy computer systems have glitches A voluntary assessment of electronic pharmacy systems in Pennsylvania facilities showed the systems are not detecting all unsafe drug orders,...

Know what questions to ask to assess drug interaction.
September 1, 2007... Know what questions to ask to assess drug interaction 10 questions to assess situation Researchers at the University of Washington have developed a 10-question format as part of a Drug Interaction Probability Scale (DIPS) to provide a...

News Briefs.
September 1, 2007... Pharmacy groups create pandemic flu guide The American Pharmacists Association, American Society of Health-System Pharmacists, and National Association of Chain Drug Stores Foundation have collaborated to produce a guide to help pharmacists...

New FDA Approvals.
September 1, 2007... The Food and Drug Administration recently announced the following approvals: • FDA has approved Gilead Sciences' Letairis (ambrisentan) for treating pulmonary arterial hypertension. Letairis, a new drug not previously approved in the U.S.,...

Drug Criteria & Outcomes: Retapamulin (Altabax[trademark]) Formulary Evaluation.(Drug overview)
September 1, 2007... .table { border: 1px; border-collapse: collapse; border-style: outset; border-color: #000000} Drug Criteria & Outcomes Retapamulin (Altabax™) Formulary Evaluation By Sarita Bhat, Pharm.D. Candidate, Auburn (AL) University ...

CE objectives/questions.(continuing education)(Brief article)
September 1, 2007... CE objectives/questions This CE program will improve participants' ability to: *Compare the clinical efficacy and safety of one therapeutic agent over another used in the same setting. *Assess clinical trial data and explain how...